Interleukin-6 and soluble interleukin-2 receptor alpha - Markers of inflammation in patients with psoriatic arthritis?

Clinical and Experimental Rheumatology

Volumn 27, Issue 1, 2009, Pages 120-123

  Alenius, Gerd Marie ^a   Eriksson, Catharina ^a   Dahlqvist, Solbritt Rantapää ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytokine; IL 2sR alpha; IL 6; Psoriatic arthritis

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6;

ADULT; ARTHRITIS; ARTHROPATHY; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PSORIATIC ARTHRITIS; SKIN DISEASE;

ADULT; AGED; ARTHRITIS, PSORIATIC; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 63049139677     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. MOLL JMH, WRIGHT V: Psoriatic arthritis. Semin Arthritis Rheum 1973; 3: 55-78.
2. HELLIWELL PS, WRIGHT V: Spondylarthropathies: Psoriatic arthritis: Clinical features. In KLIPPEL JH, DIEPPE PA (Eds.) Rheumatology. London: Mosby-Year Book Europe Limited; 1994: 3: 31.3).
3. GLADMAN DD, SHUCKETT R, RUSSEL ML, THORNE JC SCHACHTER RK: Psoriatic arthritis (PSA) - An analysis of 220 Patients. Quart J Med 1987; 62: 127-41.
4. RITCHLIN C, HAAS-SMITH SA, HICKS D, CAPPICCIO J, OSTERLAND CK, LOONEY RJ: Patterns of cytokine production in psoriatic synovium J Rheumatol 1998; 25: 1544-52.
5. HÖHLER T, GROSSMANN S, STRADMANN-BELLINGHAUSEN B et al.: Differential association of polymorphisms in the TNFα region with psoriatic arthritis but not psoriasis. Ann Rheum Dis 2002; 61: 213-8.
6. ALENIUS GM, FRIBERG, C, NILSSON S, WAHLSTRÖM J, RANTAPÄÄ DAHLQVIST S, SAMUELSSON L: Analysis of 6 genetic loci for disease susceptibility in psoriatic arthritis. J Rheumatol 2004; 31: 2230-5.
7. ELKAYAM O, YARON I, SHIRAZI I, YARON M, CASPI D: Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis. Rheumatol Int 2000; 19: 101-5.
8. SPADARO, A, TACCARI E, RICCERI V, SENSI F, SILI SCAVALLI A, ZOPPINI A: Interleukin-6 and soluble interleukin-2-receptor in psoriatic arthritis: correlations with clinical and laboratory parameters. Clin Exp Rheumatol 1996; 14: 413-6.
9. COOPERATING CLINICS COMMITTEE OF THE AMERICAN RHEUMATISM ASSOCIATION: A seven-day variability study of 488 patients with peripheral rheumatoid arthritis. Arthritis Rheum 1965; 8: 302-34.
10. BENNET PH, BURCH TA: Population studies of the rheumatic diseases. Amsterdam: Excerpta Medica Foundation; 1968: 456-7.
11. ROMANUS R, YDÉN S: Pelvo-spondylitis ossificans. Rheumatoid or ankylosing spondylitis - a roentgenological and clinic guide to its early diagnosis. Copenhagen: Munksgaard; 1955: 28-34.
12. TAYLOR W, GLADMAN D, HELLIWELL P, MARCHESONI A, MEASE P, MIELANTS H; CASPAR STUDY GROUP: Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum 2006: 54; 2665-73.